FDA NDC Directory · JSON-LD · Markdown

Avopef

NDC 83831-145 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameetoposide
Labeler / ManufacturerAVYXA Pharma, LLC
Marketing categoryNew Drug Application (innovator) · App NDA220200
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsETOPOSIDE (500 mg/25mL)
Marketing started20260914
Package count1

External sources

Source: openFDA. Public-domain (CC0).